Rize

Name

Rize

Website

https://rizelab.com

Company type

Private

Founded year

2013

Headcount range

51–100 employees

Short description

Rize is a private clinical diagnostic laboratory in Corvallis, Oregon, founded in 2013, that performs COVID-19 testing and toxicology services for referring healthcare providers and related clients with a 51-100 person staff.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industry

Local/County Public Health Laboratories (HLAJAIAC)

Keywords

• Clinical diagnostic laboratory
• COVID-19 testing
• Toxicology screening
• Diagnostic lab services
• Clinical specimen analysis

Headquarters

HQ city

Corvallis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure

Core offering

Rize is a clinical diagnostic laboratory that performs COVID-19 testing and toxicology screening on specimens submitted to its Corvallis, United States facility. The lab operates as a for-profit, privately held clinical testing service with 51–100 employees, providing diagnostic results to healthcare providers and patients. It is not described as a software, platform, or marketplace business — its core output is laboratory test results.

Differentiator

Problem solved

Functional benefit

Products and services

• COVID-19 Testing Clinical laboratory diagnostic testing for SARS-CoV-2 (COVID-19), performed at Rize's Corvallis laboratory on specimens submitted by referring healthcare providers and/or patients. The service delivers test results that inform clinical, occupational, or public-health decision-making.
• Toxicology Screening Clinical laboratory toxicology screening performed at Rize's Corvallis laboratory, typically used to support medication monitoring, substance-use treatment programs, occupational health testing, or compliance-related drug screening. The service provides analytical results on specimens submitted by referring healthcare providers.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• NMS Labs: Pennsylvania-based specialty forensic and clinical toxicology laboratory performing reference-level drug testing, pain management, and postmortem toxicology. Directly comparable to Rize's toxicology business line, competing for esoteric reference toxicology work.
• US Drug Testing Laboratories (USDTL): Specialty toxicology laboratory focused on substance use disorder, fetal alcohol research, and clinical drug monitoring. Comparable to Rize's toxicology offering, particularly for specialty panels and clinical monitoring applications.
• Pacific Toxicology Laboratories: California-based specialty toxicology laboratory serving pain management, addiction medicine, and occupational health clients. Comparable to Rize's toxicology service line and a regional competitor for West Coast accounts.
• BioReference Laboratories (an OPKO Health company): Full-service clinical laboratory offering routine and specialty diagnostics, including significant COVID-19 and infectious disease testing capacity. Comparable to Rize across both of its core specialties and a likely competitor for regional physician accounts.
• Omega Laboratories: Specialty toxicology and forensic drug testing laboratory with workplace, legal, and clinical testing capabilities. Comparable to Rize's toxicology business, particularly in employer and clinical monitoring segments.
• Aegis Sciences Corporation: Nashville-based specialty clinical laboratory focused on toxicology, medication monitoring, and drug-drug interaction testing. Closely comparable to Rize's toxicology specialty, serving pain management, behavioral health, and primary care providers.

Broad incumbents

• Eurofins Scientific: Global testing services group with significant U.S. clinical diagnostics and specialty toxicology operations. Comparable as a broad incumbent in clinical and esoteric testing, with active M&A activity in the U.S. lab market.
• Sonic Healthcare USA: International diagnostics group with significant U.S. presence through acquisitions of regional labs (e.g., Sunrise, CPL, Pathology Associates). Comparable as both an acquirer of regional labs like Rize and as a competitor for clinical and esoteric testing.
• Quest Diagnostics: Largest U.S. independent clinical reference laboratory offering routine and esoteric testing nationwide, including toxicology and infectious disease. Directly comparable as a competitor for the same physician and payer customers Rize serves, though at vastly greater scale and with a national footprint.
• Laboratory Corporation of America (LabCorp): Second-largest U.S. clinical reference lab with a broad test menu spanning routine diagnostics, infectious disease, and specialty/esoteric testing. Competes with Rize on physician outreach, payer contracts, and toxicology services, particularly for in-network clinical work.

Market position

Customer concentration

• LinkedInlinkedin.com/company/rize-laboratory

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rize